Your browser doesn't support javascript.
loading
Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement.
Gamboa, Anthony M; Kim, Sungjin; Force, Seth D; Staley, Charles A; Woods, Kevin E; Kooby, David A; Maithel, Shishir K; Luke, Jennifer A; Shaffer, Katherine M; Dacha, Sunil; Saba, Nabil F; Keilin, Steven A; Cai, Qiang; El-Rayes, Bassel F; Chen, Zhengjia; Willingham, Field F.
Afiliação
  • Gamboa AM; Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Kim S; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia.
  • Force SD; Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia.
  • Staley CA; Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Woods KE; Interventional Endoscopy, Gastroenterology and Nutrition, Cancer Treatment Centers of America, Newnan, Georgia.
  • Kooby DA; Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Maithel SK; Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Luke JA; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Shaffer KM; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Dacha S; Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Saba NF; Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Keilin SA; Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • Cai Q; Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
  • El-Rayes BF; Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Chen Z; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia.
  • Willingham FF; Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
Cancer ; 122(14): 2150-7, 2016 07 15.
Article em En | MEDLINE | ID: mdl-27142247
BACKGROUND: In considering treatment allocation for patients with early esophageal adenocarcinoma, the incidence of lymph node metastasis is a critical determinant; however, this has not been well defined or stratified by the relevant clinical predictors of lymph node spread. METHODS: Data from the Surveillance, Epidemiology, and End Results database of the National Cancer Institute were abstracted from 2004 to 2010 for patients with early-stage esophageal adenocarcinoma. The incidence of lymph node involvement for patients with Tis, T1a, and T1b tumors was examined and was stratified by predictors of spread. RESULTS: A total of 13,996 patients with esophageal adenocarcinoma were evaluated. Excluding those with advanced, metastatic, and/or invasive (T2-T4) disease, 715 patients with Tis, T1a, and T1b tumors were included. On multivariate analysis, tumor grade (odds ratio [OR], 2.76; 95% confidence interval [95% CI], 1.58-4.82 [P<.001]), T classification (OR, 0.47; 95% CI, 0.24-0.91 [P =.025]), and tumor size (OR, 2.68; 95% CI, 1.48-4.85 [P = .001]) were found to be independently associated with lymph node metastases. There was no lymph node spread noted with Tis tumors. For patients with low-grade (well or moderately differentiated) tumors measuring <2 cm in size, the risk of lymph node metastasis was 1.7% for T1a (P<.001) and 8.6% for T1b (P = .001) tumors. CONCLUSIONS: For patients with low-grade Tis or T1 tumors measuring ≤2 cm in size, the incidence of lymph node metastasis appears to be comparable to the mortality rate associated with esophagectomy. For highly selected patients with early esophageal adenocarcinomas, the results of the current study support the recommendation that local endoscopic resection can be considered as an alternative to surgical management when followed by rigorous endoscopic and radiographic surveillance. Cancer 2016;122:2150-7. © 2016 American Cancer Society.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma Tipo de estudo: Etiology_studies / Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma Tipo de estudo: Etiology_studies / Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article